Is it beneficial to increase the provision of thrombolysis?- A discrete-event simulation model

QJM: An International Journal of Medicine

Volumn 105, Issue 7, 2012, Pages 665-673

  Barton, M ^a   McClean, S ^a   Gillespie, J ^a   Garg, L ^a   Wilson, D ^b   Fullerton, K ^b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SIMULATION; STROKE; SURVIVAL;

EID: 84863768384     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs036     Document Type: Article

References (24)

1. Department of Health, Social Services and Public Safety. Improving Stroke Services in Northern Ireland. A Consultation Document (REF71/2008). Belfast, DHSSPSNI, 2008.
2. National Audit Office. Progress in Improving Stroke Care. Report by the Comptroller and Auditor General, Department of Health. London, National Audit Office, 2010.
3. Royal College of Physicians (RCP). National Sentinel Stroke Audit Report. Prepared for on behalf of the Intercollegiate Stroke Working Party. London, RCP, 2008.
4. Sudlow C, Wardlow C. Getting the priorities right for stroke care. BMJ 2009; 28:1419-22.
5. Langhorne P. Organised inpatient (stroke unit) care for stroke. Cochrane Database Sys Rev 2007; 4, Art. No.: CD000197. DOI: 10.1002/14651858.CD000197.pub2.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (NINDS). New Eng J of Med 1995; 33:51581-8.
7. Fagan SC, Morgenstern LB, Pettita A, Wars RE, Tilley BC, Marler JR, et al. Cost-effectiveness of tissue plasminogen activator for acute ischaemic stroke. Neurology 1998; 50:4 833-90.
8. Sinclair S, Frighetto L, Loewen P, Sunderji R, Teal P, Fagan SC, et al. Cost-utility of tissue plasminogen activator therapy for acute ischaemic stroke: A Canadian healthcare perspective. Pharmacoeconomics 2001; 19:927-36.
9. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39:3316-22.
10. Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischaemic stroke assessed by a model based on UK NHS figures. Stroke 2004; 35:1490-8.
11. Saka O, McGuire A, Wolfe C. Cost of Stroke in the United Kingdom. Age Ageing 2009; 38:27-32.
12. Personal Social Services Research Unit (PSSRU). Unit Costs of Health and Social Care. London, PSSRU, 2006.
13. Bebbington A, Darton R, Netton A. Care Homes for Older People: Volume 2. Admissions, Needs and Outcomes - The 1995-96 National Longitudinal Survey of Publicly-funded Admissions. London, PSSRU, 2001.
14. Xie H, Chaussalet TJ, Millard PH. A model based approach to the analysis of patterns of length of stay in institutional long-term care. IEEE T Inf Technol B 2006; 10:512-8.
15. Dorman P, Dennis M, Sandercock P. Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? J Neurol Neurosurg Ps 2000; 69:487-93.
16. National Institute for Health Clinical Excellence. Updated Guide to the Methods of Technology Appraisal. London, NICE, 2008.
17. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP. Sex-based differences in response to recombinant tissue plasminogen activator in acute ischaemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005; 36:62-5.
18. Taylor K, Lane D. Simulation applied to health services: opportunities for applying the system dynamics approach. J Health Serv Res Policy 1998; 3:226-32.
19. Faddy MJ, McClean SI. Markov chain modelling for geriatric patient care. Method Inf Med 2005; 44:369-373.
20. Marshall AH, McClean SI. Using Coxian phase type distributions to identify patient characteristics for duration of stay in hospital. Health Care Manage Sci 2004; 7:285-9.
21. McClean SI, Millard PH. Where to treat the older patient? Can Markov models help better understand the relationship between hospital and community care? J Oper Res Soc 2006; 58:255-61.
22. McClean SI, Barton M, Garg L, Fullerton K. A modelling framework to combine Markov models and Discrete Event Simulation for stroke patient care. ACM T Model Comput S (Special Issue on Healthcare) 2011; 21:4.
23. Sackley C, Pound K. Setting priorities for a discharge plan for stroke patients entering nursing home care. Clin Rehabil 2003; 16:859-66.
24. Rudd AG, Hoffman A, Grant R, Campbell J, Lowe G. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we know and how much do we need? J Neurol Neurosurg Psychiatry 2011; 82:14-9.